📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results. (2024)

First Author: Sevigny J

Attributed to: Developing an evidence base for trials in genetic frontotemporal dementia - measures of disease onset and progression funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41591-024-02973-0

PubMed Identifier: 38745011

Publication URI: http://europepmc.org/abstract/MED/38745011

Type: Journal Article/Review

Volume: 30

Parent Publication: Nature medicine

Issue: 5

ISSN: 1078-8956